Mutual Funds
Mutual Funds
Fund Profile
Scheme Profile
Daily NAV
Historical NAV
Category Returns
Dividend Details
Fund Ranking
MF Activities
All Holdings
What's In / What's Out
MF Trends
MF Tools
  Home   >   MUTUAL FUND  >  MUTUAL FUNDS  > SCHEME PROFILE
SCHEME PROFILE      
AMC : Category : Scheme :
ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G)
TypeInvestment In% of NAVNo. of sharesValue (Rs cr)
Domestic EquitiesSun Pharmaceutical Industries Ltd.12.82604523560828.5352
Domestic EquitiesDr. Reddy's Laboratories Ltd.9.81495036728634.0233
Domestic EquitiesCipla Ltd.7.99823374056516.6692
Domestic EquitiesDivi's Laboratories Ltd.7.4767745684482.9795
Domestic EquitiesAurobindo Pharma Ltd.6.03973180505390.1525
Domestic EquitiesLupin Ltd.5.70411769639368.4742
Domestic EquitiesMankind Pharma Ltd.5.03521444988325.2668
Domestic EquitiesAlkem Laboratories Ltd.3.7781429308244.0616
Domestic EquitiesSyngene International Ltd.2.96672956118191.6451
Domestic EquitiesCohance Lifesciences Ltd2.68063068016173.1588
Domestic EquitiesZydus Lifesciences Ltd.2.56971761233165.9962
Domestic EquitiesBiocon Ltd.2.20043568256142.1415
Domestic EquitiesThyrocare Technologies Ltd.2.15202804472139.0177
Domestic EquitiesAlembic Pharmaceuticals Ltd.1.84841316201119.4058
Domestic EquitiesMedi Assist Healthcare Services Ltd1.59172164815102.8179
Domestic EquitiesJ.B.Chemicals & Pharmaceuticals Ltd.1.5869578725102.5096
Domestic EquitiesGland Pharma Ltd.1.5660574908101.1608
Domestic EquitiesBlue Jet Healthcare Ltd.1.4081157246890.9594
Domestic EquitiesPfizer Ltd.1.393718097090.0326
Domestic EquitiesMedplus Health Services Ltd1.3410107108486.6293
Domestic EquitiesMetropolis Healthcare Ltd.1.309843815584.6077
Domestic EquitiesFine Organic Industries Ltd.1.165617039975.2925
Domestic EquitiesGlenmark Pharmaceuticals Ltd.1.141337882273.7263
Domestic EquitiesStar Health & Allied Insurance1.1235148741872.5786
Domestic EquitiesWindlas Biotech Ltd.1.040485765167.2055
Domestic EquitiesAnthem Biosciences Ltd1.0343105263666.8108
Domestic EquitiesShilpa Medicare Ltd.1.0183192629865.7831
Domestic EquitiesAarti Drugs Ltd.0.9559145338361.7470
Domestic EquitiesHikal Ltd.0.9153265226759.1243
Domestic EquitiesSanofi Consumer Healthcare India Ltd0.834311566753.8974
Domestic EquitiesSenores Pharmaceuticals Ltd0.817264088352.7895
Domestic EquitiesAstrazeneca Pharma India Ltd.0.76865502149.6510
Domestic EquitiesFDC Ltd.0.7683119768949.6322
Domestic EquitiesRubicon Research Ltd0.732772168047.3314
Domestic EquitiesLaxmi Dental Ltd.0.7096165463945.8418
Domestic EquitiesProcter & Gamble Health Ltd.0.63317147140.8993
Domestic EquitiesSun Pharma Advanced Research Co. Ltd0.6237299554040.2930
Domestic EquitiesAkums Drugs and Pharmaceuticals Ltd.0.13442038458.6828
Total 97.7044 6311.5312
Cash & Cash Equivalents and Net AssetsTREPS2.2253 143.7513
Cash & Cash Equivalents and Net AssetsCash Margin - Derivatives0.1301 8.4052
Cash & Cash Equivalents and Net AssetsNet Current Assets-0.0598 -3.8653
Total 2.2956 148.2912
 
Back Back TopTop
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Smart ODR Portal | Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst | UPI QR CODE
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.